Effect of oligometastatic disease management with stereotactic body radiation therapy on survival in patients with metastatic lung cancer.
2019
e13582Background: Overall survival (OS) of metastatic non-small cell lung cancer (NSCLC) patients (pts) is improving with the development of targeted therapies (TARGET) and immunotherapy (IMMUNO), ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI